More than 11 Results
Display change
TOPICS

Using invivoidTM 3D Cell Culture Technology to Assess the Efficacy of Next-generation Cancer Treatments—Joint Research Paper from TOPPAN Holdings, University of Osaka Graduate School of Engineering, Japanese Foundation for Cancer Research, and Sapporo Medical University Published in Acta Biomaterialia

In vitro replication of the barrier function of refractory cancers enables successful identification of drug candidates that break down the barrier. Aiming to contribute to businesses supporting drug discovery.
TOPICS

MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments

• 3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies• Teams will evaluate technology as clinical tool for personalized cancer therapy• Collaboration will aim to obtain CAP/CLIA certification of organoid-based assay, followed by clinical studies in multiple indications